BKLC Performance — BNY Mellon US Large Cap Core Equity ETF
Data updated: 2026-09-24
BKLC returned +10.01% year to date and +19.21% over one year to Jul 2026. Annualised returns are +20.06% over 3 years and +12.94% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $173, against $153 for the category, and to $119 over one year, against $116. Volatility over the past three years was 13.20% a year. In the 12 months to Jul 2026 the fund took in a net $995.7M, and assets reached $5.47B.
BKLC Growth of $100
What $100 invested in BNY Mellon US Large Cap Core Equity ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | BKLC | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $119 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $173 | $153 |
| 5 years (Aug 2021 – Jul 2026) | $184 | $159 |
| Since data start (Apr 2020 – Jul 2026) | $310 | $253 |
BKLC Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +10.01% |
| 1 year | +19.21% |
| 3 years (annualised) | +20.06% |
| 5 years (annualised) | +12.94% |
BKLC Annual Returns
Calendar-year total returns of BNY Mellon US Large Cap Core Equity ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +10.01% |
| 2025 | +18.09% |
| 2024 | +25.55% |
| 2023 | +30.69% |
| 2022 | −20.39% |
| 2021 | +27.20% |
| 2020 (Apr–Dec) | +43.83% |
BKLC Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.2% | −0.8% | −4.9% | +10.6% | +5.5% | −0.9% | −0.3% | — | — | — | — | — |
| 2025 | +3.1% | −1.6% | −5.9% | −0.4% | +6.5% | +5.2% | +2.3% | +2.0% | +3.8% | +2.4% | +0.1% | 0.0% |
| 2024 | +1.7% | +5.4% | +3.1% | −4.0% | +4.8% | +3.7% | +1.1% | +2.5% | +2.2% | −0.7% | +6.2% | −2.5% |
| 2023 | +6.1% | −2.3% | +4.8% | +1.8% | +1.4% | +6.3% | +3.3% | −1.1% | −4.6% | −1.7% | +9.4% | +4.5% |
| 2022 | −5.5% | −3.4% | +3.7% | −9.5% | −0.4% | −8.0% | +9.3% | −4.1% | −9.2% | +7.8% | +5.2% | −6.0% |
| 2021 | −1.0% | +1.9% | +4.0% | +5.5% | +0.2% | +3.2% | +2.6% | +3.0% | −4.9% | +7.1% | −0.7% | +3.9% |
| 2020 | — | — | — | +9.7% | +4.7% | +2.3% | +5.9% | +8.5% | −4.2% | −3.4% | +10.9% | +3.9% |
BKLC Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 13.20%
- 3-year Sharpe ratio: 1.18 (vs 4.5% risk-free rate)
- Best month: +10.58% (Apr 2026)
- Worst month: −5.90% (Mar 2025)
BKLC Fund Flows
Monthly money in and out of BNY Mellon US Large Cap Core Equity ETF, from SEC Form N-PORT.
- 12-month net flow: $995.7M
- 12-month gross sales (incl. reinvestments): $2.7B
- Sales ÷ redemptions: 1.59×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $131.6M | $74.0M | $57.5M |
| Jun 2026 | $143.1M | $78.1M | $65.0M |
| May 2026 | $98.3M | $229.1M | −$130.7M |
| Apr 2026 | $754.1M | $383.6M | $370.5M |
| Mar 2026 | $97.1M | $692.0M | −$594.9M |
| Feb 2026 | $225.8M | $57.7M | $168.1M |
| Jan 2026 | $196.3M | $21.2M | $175.1M |
| Dec 2025 | $52.5M | $0 | $52.5M |
| Nov 2025 | $87.7M | $13.1M | $74.5M |
| Oct 2025 | $358.0M | $90.1M | $267.9M |
| Sep 2025 | $471.0M | $34.6M | $436.4M |
| Aug 2025 | $53.8M | $0 | $53.8M |
BKLC Assets Under Management
Net assets of BNY Mellon US Large Cap Core Equity ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $5.47B |
| 2026-04-30 | $5.26B |
| 2026-01-30 | $5.16B |
| 2025-10-31 | $4.81B |
| 2025-07-31 | $3.73B |
| 2025-04-30 | $2.58B |
| 2025-01-31 | $3.27B |
| 2024-10-31 | $2.88B |
| 2024-07-31 | $2.49B |
| 2024-04-30 | $2.25B |
| 2024-01-31 | $2.10B |
| 2023-10-31 | $1.69B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.